{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:59:57Z","timestamp":1787014797997,"version":"build-2736575974"},"reference-count":60,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T00:00:00Z","timestamp":1319068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Comparative Oncology"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:p>Thymidine kinase 1 (TK1) is a soluble biomarker associated with DNA synthesis. This prospective study evaluated serum TK1 activity in dogs presenting with hemoabdomen and a splenic mass. An ELISA using azidothymidine as a substrate was used to evaluate TK1 activity. Sixty\u2010two dogs with hemoabdomen and 15 normal controls were studied. Serum TK1 activity was significantly higher in dogs with hemangiosarcoma (HSA) than in normal dogs (mean \u00b1 SEM = 17.0 \u00b1 5.0 and 2.01 \u00b1 0.6, respectively), but not dogs with benign disease (mean \u00b1 SEM = 10.0 \u00b1 3.3). Using a cut\u2010off of 6.55 U\/L, TK activity demonstrated a sensitivity of 0.52, specificity of 0.93, positive predictive value of 0.94 and negative predictive value of 0.48 for distinguishing HSA versus normal. When interval thresholds of &lt;1.55 and &gt;7.95 U\/L were used together, diagnostic utility was increased. Serum TK1 evaluation may help to discriminate between benign disease and HSA in dogs with hemoabdomen and a splenic mass.<\/jats:p>","DOI":"10.1111\/j.1476-5829.2011.00298.x","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T03:45:39Z","timestamp":1319082339000},"page":"292-302","source":"Crossref","is-referenced-by-count":23,"title":["Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma\n                    <sup>*<\/sup>"],"prefix":"10.1111","volume":"10","author":[{"given":"D. H.","family":"Thamm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Kamstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. R.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. I.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. V.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. A.","family":"Selting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(95)00015-9"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2010.00238.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1016\/S0021-9258(18)68484-4","article-title":"Regulation of human thymidine kinase during the cell cycle.","volume":"263","author":"Sherley JL","year":"1988","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_7_5_2","doi-asserted-by":"crossref","first-page":"13836","DOI":"10.1016\/S0021-9258(17)36723-6","article-title":"Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus\u2010transformed cells.","volume":"269","author":"Hengstschlager M","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1983.78"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01726414"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/15257771003738535"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-010-0769-z"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509064927"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03058.x"},{"key":"e_1_2_7_12_2","first-page":"918","article-title":"Prognostic factors in multiple myeloma: role of beta 2\u2010microglobulin and thymidine kinase.","volume":"71","author":"Diem H","year":"1993","journal-title":"Clinical Investigation"},{"key":"e_1_2_7_13_2","first-page":"233","article-title":"Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma.","volume":"12","author":"Musolino C","year":"1990","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011138825593"},{"key":"e_1_2_7_15_2","first-page":"1732","article-title":"Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.","volume":"93","author":"Hallek M","year":"1999","journal-title":"Blood"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609054782"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPHMYT93HUIZKW"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03390.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1043114"},{"key":"e_1_2_7_20_2","first-page":"1013","article-title":"Concentration of thymidine kinase 1 in serum (S\u2010TK1) is a more sensitive proliferation marker in human solid tumors than its activity.","volume":"14","author":"He Q","year":"2005","journal-title":"Oncology Reports"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.2880150510"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0045(199607)29:1<15::AID-PROS2>3.0.CO;2-H"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0748-7983(95)95434-1"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2008.00970.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0b013e328329d817"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-010-0067-4"},{"key":"e_1_2_7_27_2","first-page":"3897","article-title":"Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours.","volume":"28","author":"Chen Z","year":"2008","journal-title":"Anticancer Research"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.59.957"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1892\/0891-6640(2004)18<696:STKAID>2.0.CO;2"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2005.05.001"},{"key":"e_1_2_7_31_2","first-page":"505","article-title":"Monitoring therapy in canine malignant lyphoma and leukemia with serum thymidine kinase 1 activtiy \u2013 evaluation of a new, fully automated non\u2010radiometric assay.","volume":"34","author":"von Euler H","year":"2008","journal-title":"International Journal of Oncology"},{"key":"e_1_2_7_32_2","volume-title":"The Occurrence of Tumors in Domestic Animals .","author":"Priester W","year":"1980"},{"key":"e_1_2_7_33_2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2460\/javma.1992.201.05.773","article-title":"Prevalence and type of splenic diseases in cats: 455 cases (1985\u20131991).","volume":"201","author":"Spangler WL","year":"1992","journal-title":"Journal of the American Veterinary Medical"},{"key":"e_1_2_7_34_2","first-page":"199","volume-title":"Onderstepoort Journal of Veterinary Research","author":"Bastianello SS.","year":"1983"},{"key":"e_1_2_7_35_2","first-page":"307","article-title":"Survey of animal neoplasms in Alameda and Contra Costa Counties. Cancer morbidity in dogs and cats from Alameda County.","volume":"40","author":"Dorn CR","year":"1968","journal-title":"Journal of the National Cancer Institute"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/030098587801500602"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.1995.tb02769.x"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1997.tb00085.x"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.5326\/0390518"},{"key":"e_1_2_7_40_2","first-page":"56","article-title":"Canine hemangiosarcoma: retrospective analysis of 104 cases.","volume":"186","author":"Brown NO","year":"1985","journal-title":"Journal of the American Veterinary Medical"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/104063870401600606"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2000.tb02247.x"},{"key":"e_1_2_7_43_2","first-page":"1165","article-title":"Liposome\u2010encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi\u2010institutional clinical trial.","volume":"1","author":"Vail DM","year":"1995","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-165X.2005.tb00005.x"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1989.tb03092.x"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2008.125m4.x"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.232.4.553"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.5326\/0450072"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.2004.04094.x"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2008.0154.x"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.234.1.88"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.2004.04054.x"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2004.tb02554.x"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.237.7.806"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2004.tb02552.x"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2001.tb01244.x"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11259-010-9445-7"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2011.0709.x"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.04.013"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(97)00132-0"},{"key":"e_1_2_7_61_2","first-page":"3007","article-title":"Circadian variations of interleukin\u20102 receptors, serum thymidine kinase and beta\u20102 microglobulin in patients with non\u2010Hodgkin's lymphoma and normal controls.","volume":"17","author":"Micke O","year":"1997","journal-title":"Anticancer Research"}],"container-title":["Veterinary and Comparative Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5829.2011.00298.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5829.2011.00298.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T18:49:45Z","timestamp":1713034185000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5829.2011.00298.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,20]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1476-5829.2011.00298.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5829.2011.00298.x","archive":["Portico"],"relation":{},"ISSN":["1476-5810","1476-5829"],"issn-type":[{"value":"1476-5810","type":"print"},{"value":"1476-5829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,20]]}}}